NEW YORK (GenomeWeb) – Illumina has won a patent infringement lawsuit against Roche's Ariosa Diagnostics related to the companies' noninvasive prenatal tests. A jury in the US District Court of the Northern District of California awarded Illumina $26.7 million in damages.
Menu
Home › Tools & Technology › Microarrays & Multiplexing › Illumina Awarded $26.7M in NIPT Patent Suit Against Ariosa
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.
By MilliporeSigma
By MilliporeSigma
By MilliporeSigma
Mar
18
Featured Webinar
Molecular Multi-Target Assay Design Coupled with Reflex Testing with SARS-CoV-2 Mutations in Mind
Sponsored by
Thermo Fisher Scientific
Mar
29
Featured Webinar
Think Globally, Act Locally: The Importance of Coordinated Global and Community Genetic Surveillance Programs
Sponsored by
Thermo Fisher Scientific
Mar
31
Sponsored by
MilliporeSigma
What's Popular?
In Molecular Diagnostics
Sponsorships
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.